Precision Genomics Collaboratory News

Lipid Serendipity

A newly discovered protein modification opens up another world of discovery

Over 200 million people worldwide take statins to help lower their cholesterol, which helps reduce the risk of illness and mortality for those in danger of contracting heart disease. But there is a lot about statins that researchers don’t yet understand.

How Fast are You Aging?

Five decades ago, Duke psychologists Terrie Moffitt and Avshalom Caspi began working with a long-term study of 1,000 people in New Zealand to get a better perspective on how childhood factors may have led to adolescent behaviors, such as risk-taking.

Reflections From the Upcoming T32 Graduates

The Duke Center for Precision Medicine is pleased to announce the newest upcoming graduates of the Post-Doctoral Training in Genomic Medicine Research Program – Sarah Heston, MD, and Nathan Bihlmeyer, PhD. The post-doctoral training program is supported by an NIH-training award (T32).

Dr. Heston and Dr. Bihlmeyer both reflected on their rewarding time as post-docs. The two-year training program began during July of 2020 and will conclude at the end of June 2022.

PGC Announces Student Pilot Grant Awardees

The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 10 pilot grants of $2,000 each to SOM Biomedical PhD students. The goal of these grants is to support our students in scientific and educational efforts to bolster their graduate training experiences. These awards will help further research in a broad array of topics including into diseases like breast cancer, glioblastoma, meningitis, and more.

PGC Spring Newsletter

Latest news, events, funding opportunities and publications from the Precision Genomics Collaboratory